Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Thomas Meyer
CEO | Chief Executive Officer | 56 | 01.04.03 |
Marcel Gremaud
DFI | Director of Finance/CFO | 66 | 01.11.21 |
Covadonga Pañeda
COO | Chief Operating Officer | 51 | - |
Samuel Wickline
CTO | Chief Tech/Sci/R&D Officer | 71 | 01.06.21 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Alain Munoz
BRD | Director/Board Member | 75 | 01.03.18 |
Mats Blom
BRD | Director/Board Member | 59 | 01.04.17 |
Thomas Meyer
CEO | Chief Executive Officer | 56 | 01.04.03 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 2 240 245 | 2 220 245 ( 99,11 %) | 0 | 99,11 % |
Unternehmenskontakt
Altamira Therapeutics Ltd.
Clarendon House 2 Church Street
HM 11, Hamilton
+441 295 5950
http://www.altamiratherapeutics.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+9.42% | 115 Mrd. | |
+11.84% | 106 Mrd. | |
-14.15% | 21.84 Mrd. | |
-1.05% | 21.96 Mrd. | |
-5.29% | 19.21 Mrd. | |
-38.29% | 17.71 Mrd. | |
-4.16% | 18.08 Mrd. | |
+7.99% | 14.32 Mrd. | |
+36.24% | 12.42 Mrd. |